Brief: Diaxonhit buys GENBIO in USA
19/07/2017 16:46
July 19 (Reuters) - Diaxonhit SA ALEHT.PA
* ACQUISITION OF GENBIO IN USA
* PURCHASE PRICE OF TWO MILLION US DOLLARS PAID IN THREE
TRANCHES, FIRST TWO OF WHICH ARE FINANCED BY A BANK LOAN
Source text for Eikon: ID:nGNE666MLz
Further company coverage: ALEHT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million